AnandRathi

Neuland Laboratories Ltd Fundamental Analysis

Last Updated Date: 16 Oct 2026
₹19,699.70
-243.10 (-1.22%)

Neuland Laboratories Ltd (Neuland Labs.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹25,275 crore.

Neuland Laboratories Ltd Overview

Market cap₹25,275 Crs
Volume1,301
Prev. Close₹19,942.80
Year range₹11,500.00 - ₹24,235.05
ISININE794A01010

Neuland Laboratories Ltd Fundamentals

ROCE(TTM)23.61%
P/E Ratio (TTM)50.88
P/B Ratio13.55
Debt to Equity0.16
ROE19.46%
EPS (TTM)387.19
Dividend Yield0.17%
Book Value1453.59
Profit Margin20.94%
Operating Margin27.97%

Neuland Laboratories Ltd Historical Performance

1 Month Return-13.04%
6 Month Return31.46%
3 Year Return413.47%
3 Month Return4.93%
1 Year Return21.73%
5 Year Return1035.76%

Neuland Laboratories Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research